MarkBernardEffronMD

PubMed

• 71 citations
  Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Co...
  Larry R. Jackson, Christine Ju, Marjorie Zettler, John C. Messenger, David J. Cohen
  JACC. Cardiovascular Interventions. 2015-12-21
• 42 citations
  Elastic properties of the human chest during cardiopulmonary resuscitation
  Joshua E. Tsitlik, Myron L. Weisfeldt, Nisha Chandra, Mark B. Effron, Henry R. Halperin
  Critical Care Medicine. 1983-09-01
• 305 citations
  Mechanisms of blood flow during cardiopulmonary resuscitation.
  M. T. Rudikoff, W L Maughan, Mark B. Effron, P. Freund, Myron L. Weisfeldt
  Circulation. 1980-02-01

Journal Articles

• Incidence, predictors and impact of stroke after percutaneous coronary intervention for acute coronary syndromes: results from the PROMETHEUS registry  
  Giustino G, Baber U, Sartori S, Aoi S, Aquino M, Chandrasekhar J, Weintraub W, Rao S; Weiss S, Henry T, Kapadia S. Poddar K, DeFranco A, Muhlestein J, Toma C, Effron M..., J Am Coll Cardiol, 1/1/2016
• How reliable are patient-reported rehospitalizations? Implications for the design of future practical clinical studies  
  Krishnamoorthy A, Peterson ED, Knight JD, Anstrom KJ, Effron MB, Zettler ME, Davidson-Ray L, Baker BA, McCollam PL, Mark DB, Wang TY, J Am Heart Assoc, 1/1/2016
• Unplanned inpatient and observation rehospitalizations after acute myocardial infarction insights from the treatment with adenosine diphosphate receptor inhibitors: Lo...  
  Hess CN, Wang TY, McCoy LA, Messenger JC, Effron MB, Zettler ME, Henry TD, Peterson ED, Fonarow GC, Circulation, 1/1/2016
• Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention treated with clopidogrel or prasugrel  
  Bae JP, Faries DE, Ernst FR, Lipkin C, Zhao Z, Moretz C, Lieu HD, Effron MB, Am J Health-Syst Pharm, 1/1/2016
• Impact of bleeding on quality of life in patients on DAPT: Insights from TRANSLATE-ACS  
  Amin AP, Wang TY, McCoy L, Bach RG, Effron MB, Peterson ED, Cohen DJ, J Am Coll Cardiol, 1/1/2016
• Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from ...  
  Chandrasekhar J, Usman Baber U, Samantha Sartori S, Michela Faggioni M et al, Catheterization Cardiovasc Intv, 1/1/2016
• Use of clopidogrel versus prasugrel in patients undergoing percutaneous coronary intervention: factors influencing real-world therapeutic decision-making  
  Salianski O, Baber U, Sartori S, Aoi S, Aquino M, Chandrasekhar J, Kini A, Rao S, Weintraub W, Weiss S, Henry T, Kapadia S, Poddar K, DeFranco A, Muhlestein J, Toma C,..., J Am Coll Cardiol, 1/1/2016
• Predictors of 1 year net adverse cardiovascular events (NACE) among ACS patients undergoing PCI with clopidogrel or prasugrel: analysis from the PROMETHEUS registry  
  Wayangankar SA, Baber U, Poddar K, Weiss S, Henry T, Muhlestein J, Baker B, Mehran R, Kini A, Sartori S, Rao S, Weintraub W, Strauss C, DeFranco A, Toma C, Keller S, E..., J Am Coll Cardiol, 1/1/2016
• The association of discharge aspirin dose with outcomes after acute myocardial infarction: insights from the TRANSLATE-ACS study  
  Xian Y, Wang TY, McCoy LA, Effron MB, Henry TD, Bach RG, Zettler ME, Baker BA, Fonarow GC, Peterson ED, Circulation, 1/1/2015
• One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treate...  
  Simeone JC, Molife C, Marrett E, Frech-Tamas F, Effron MB, Nordstrom BL, Zhu E, Keller S, Murphy BR, Nair KV, Vetrovec G, Page RL, McCollam PL, Am J Cardiovasc Drugs, 1/1/2015
• Outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention receiving an oral anticoagulant and dual antiplatelet therapy: a co...  
  Jackson II LR, Ju C, Zettler M, Messenger JC, Cohen DJ, Stone GW, Baker BA, Effron MB, Peterson ED, Wang TY, J Am Coll Cardiol Intv, 1/1/2015
• Contemporary use of platelet function and pharmacogenomic testing among acute myocardial infarction patients undergoing percutaneous coronary intervention in the Unite...  
  Wang TY, Henry TD, McCoy LA, Berger PB, Cohen DJ, Effron MB, Zettler M, Baker BA, Messenger JC, Peterson ED, Am Heart J, 1/1/2015
• ADP receptor inhibitor therapy use beyond 12 months in community practice: Results from the TRANSLATE-ACS registry  
  Hansen JD, McCoy LA, Cohen DJ, Henry TD, Gregg Fonarow GC, Effron MB, Zettler ME, Baker BA, Peterson ED, Wang TY, Circulation, 1/1/2015
• Switching of ADP receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the TRANSLATE-ACS observational study  
  Zettler ME, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Henry TD, Baker BA, Messenger JC, Cohen DJ, Wang TY, Circulation, 1/1/2015
• Cluster-randomized clinical trial examining the impact of platelet function testing on practice: The TReatment with Adenosine diphosphate receptor iNhibitorS: Longitud...  
  Wang TY, Henry TD, Effron MB, Honeycutt E, Hess CN, MD, Zettler ME, Cohen DJ, Baker BA, Berger PB, Anstrom KJ, Angiolillo DJ, Peterson ED, Circ Cardiovasc Interv, 1/1/2015
• Early medication nonadherence after acute myocardial infarction: Insights into actionable opportunities from the TReatment with ADP receptor iNhibitorS: Longitudinal A...  
  Mathews R, Peterson ED, Honeycutt E, Chin CT, Effron MB, Zettler M, Fonarow GC, Henry TD, Wang TY, Circ Cardiovasc Qual Outcomes, 1/1/2015
• Temporal associations between myocardial infarction, major bleeding and mortality risk in ACS patients undergoing PCI: Insights from the PROMETHEUS cohort  
  Baber U, Chao J, Chandrasekhar J, Sartori S, Aquino M, Kini A, Rao S, Weintraub W, Weiss S, Strauss C, Kapadia S, Henry T, DeFranco A, Muhlestein B, Toma C, Pocock S, ..., J Am Coll Cardiol, 1/1/2015
• Selection of prasugrel versus clopidogrel among myocardial infarction patients with high versus low predicted mortality and bleeding risks: Insights from TRANSLATE-ACS  
  Vora A, Peterson E, McCoy L, Effron M, Anstrom K, Faries D, Zettler M, Fonarow G, Baker B, Stone G, Wang T, J Am Coll Cardiol, 1/1/2015
• Impact of proton pump inhibitor use on the comparative safety and effectiveness of prasugrel versus clopidogrel: Insights from TRANSLATE-ACS  
  Jackson L, Peterson E, McCoy L, Ju C, Zettler M, Baker B, Messenger J, Faries D, Effron M, Cohen D, Wang T, J Am Coll Cardiol, 1/1/2015
• Clinical outcomes using prasugrel or ticagrelor based on physician treatment decisions in patients with acute coronary syndrome undergoing percutaneous coronary interv...  
  Effron MB, Nair KV, Molife C, Keller SY, Page RL, Simeone J, Murphy B, Nordstrom BL, McCollam PL, Vetrovec GW, J Am Coll Cardiol, 1/1/2015
• Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study  
  Chandrasekhar J, Baber U, Sartori S, Aquino M, Henry TD, Kini A, Kapadia S, Rao S, Weiss S, Muhlestein JB, Poddar KL, Baker BA, Keller SY, Effron MB, Chao J, Strauss C..., J Am Coll Cardiol, 1/1/2015
• Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS Study  
  Chandrasekhar J, Baber U, Sartori S, Aquino M, DeFranco A, Muhlestein JB, Weiss S, Henry TD, Effron MB, Strauss CE, Keller SY, Baker BA, Weintraub W, Chao J, Poddar KL..., J Am Coll Cardiol, 1/1/2015
• Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS Study  
  Chandrasekhar J, Baber U, Sartori S, Aquino M, Strauss CE, Muhlestein JB, Weiss S, Effron MB, Keller SY, Baker BA, Chao J, Rao S, Kapadia S, Poddar KL, DeFranco A, Kin..., J Am Coll Cardiol, 1/1/2015
• Switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into...  
  Bagai A, Peterson ED, Honeycutt E, Effron MB, Cohen DJ, Goodman SG, Anstrom KJ, Gupta A, Messenger JC, Wang TY, Eur Heart J Acute Cardiovasc Care, 1/16/2014
• Pharmacodynamic Evaluation of switching from ticagrelor to prasugrel in subjects with stable coronary artery disease: Results of the SWAP-2 study  
  Angiolillo DJ, Curzen N, Gurbel P, Vaitkus P, Lipkin F, Li W, Jakubowski JA, Zettler M, Effron MB, and Trenk D, J Am Coll Cardiol, 1/1/2014
• Join now to see all

Books/Book Chapters

• Scientific American Medicine 
  Chapter: Circulatory shock 
  Page 1 - 11Effron MB, Chernow BEditors: Rubenstein E, Federman DD.1992

Abstracts/Posters

• Efficacy and safety of pretreatment among contemporary acute myocardial infarction patients treated with percutaneous coronary intervention: insights from the TRANSLAT...
  Effron MB, Wang TY, Fonarow GC, Henry TD, Zettler M, Baker BA, McCoy LA, Peterson ED, J Am Coll Cardiol, 1/1/2014
• Triple therapy after acute myocardial infarction: a comparison of clopidogrel vs. prasugrel from the TRANSLATE-ACS study.
  Jackson L, Zettler M, Peterson ED, Ju C, Effron MB, Messenger J, Cohen D, Stone G, Wang TY, J Am Coll Cardiol, 1/1/2014
• A Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 study.
  Angiolillo DJ, Curzen N, Gurbel PA, Vaitkus P, Lipkin F, Jakubowski JA, Zettler M, Effron MB, Trenk D, Circulation, 1/1/2013
• High on-treatment platelet reactivity among contemporary acute myocardial infarction patients treated with percutaneous coronary intervention: Insights from the TRANSL...
  Bagai A, Peterson E, Honeycutt E, Effron MB, Stone G, Henry TD, Cohen D, Anstrom K, Wang TY, J Am Coll Cardiol, 1/1/2013
• Comparative effectiveness of prasugrel vs. clopidogrel among acute myocardial infarction patients treated with percutaneous coronary intervention: 30-day outcomes from...
  Wang TY, Zettler M, Effron MB, McCoy L, Anstrom K, Fonarow GC, Messenger JC, Stone G, Cohen D, Henry TD, Peterson E, J Am Coll Cardiol, 1/1/2013
• Contemporary use of platelet function and pharmacogenomics testing among acute myocardial infarction patients treated with PCI in the United States: insights from the ...
  Wang TY, Henry TD, Mccoy LA , Berger PB, Cohen DJ, Effron MB, Zettler M, Vaitkus PT, Messenger JC, Peterson ED, Eur Heart J, 1/1/2013
• The Association of Discharge Aspirin Dose and Outcomes in Acute Myocardial Infarction: Insights from the TRANSLATE-ACS Study.
  Xian Y, Wang T, Kaltenbach L, Effron M, Henry T, Bach R, Zettler M, Vaitkus P, Fonarow G, Peterson E, J Am Coll Cardiol, 1/1/2013
• Early Cessation of ADP Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated with PCI: Insights from the TRANSLATE-ACS Study.
  Fosbol EL, Peterson E, Honeycutt E, Zettler M, Messenger L, Waksman R, Effron M, Vaitkus P, Cohen D, Wang T, J Am Coll Cardiol, 1/1/2013
• Medication nonadherence among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights from the TRANSLATE-ACS study.
  Mathews R, Peterson E, Honeycutt E, Chin CT, Ryan K, Effron M, Zettler M, Rozek M, Henry T, Wang T, J Am Coll Cardiol, 1/1/2012
• Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: The TRIPLET trial.
  Diodati J, Fung A, Saucedo J, Mehta A, Oguzhan A, Gaxiola E, Sarmento-Leite R, Belardi J, French J, Cardillo T, Effron M, Fisher H, Angiolillo DJ, EuroIntervention, 1/1/2012
• Medication adherence and persistence of prasugrel initiators post ACS-PCI.
  Simeone JC, Nordstrom B, Zhao Z, Molife C, McCollam PL, Ye X, Effron MB, Value in Health, 1/1/2012
• Characteristics of patients treated with thienopyridines following ACS-PCI.
  Nordstrom B, Simeone JC, Zhao Z, Molife C, McCollam PL, Ye X, Effron MB, Value in Health, 1/1/2012
• Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: high on-treatment platelet reactivity analysis of the TRIPLET...
  Diodati J, Angiolillo D, Saucedo J, Cardillo T, Jakubowski J, Henneges C, Effron M, Lipkin F, Fisher H, J Am Coll Cardiol, 1/1/2012
• Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.
  Braun OO, Angiolillo DJ, Ferreiro JL, Jakubowski JA, Winters KL, Effron MB, Duvvuru S, Costigan TM, Sundseth S, Walker JR, Jorge F Saucedo JF, Neal S Kleiman NS, David..., Circulation, 1/1/2012
• Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: A Report from TRANSLATE-ACS.
  Hess CN, Wang TY, Kaltenbach L, Emily Honeycutt E, Messenger JC, Smith WT, Zettler ME, Effron MB, Henry TD, Peterson ED, Fonarow GC, Circulation, 1/1/2012
• In-hospital switching of ADP receptor inhibitors in myocardial infarction patients treated with percutaneous coronary intervention: insights from the TRANSLATE-ACS study.
  Bagai A, Peterson ED, Honeycutt E, Effron MB, Cohen DJ, Goodman SG, Anstrom K, Anjan Gupta A, Messenger JC, Wang TY, Circulation, 1/1/2012
• Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: The TRIPLET trial.
  Diodati JG, Fung A, Saucedo JF, Oguzhan A, Gaxiola E, Cardillo TE, Effron MB, Fisher HN, Henneges C, Angiolillo DJ, Can J Cardiol, 1/1/2012
• Post-discharge bleeding and thienopyridine discontinuation among AMI patients treated with PCI: insights from the TRANSLATE-ACS study.
  Wang TY, Honeycutt E, Henry TD, Effron MB, Messenger JC, Cohen DJ, Mark DB, Stone GW, Singh M, Rozek M, Fonarow GC, Peterson ED, J Am Coll Cardiol, 1/1/2011
• Lack of rebound in platelet reactivity following cessation of prasugrel or clopidogrel in type 2 diabetes mellitus patients with coronary artery disease: insights from...
  Angiolillo DJ, Jakubowski JA, Frelinger AL, Zafar MU, Saucedo JF, Michelson AD, Zhu B, Ojeh CK, Baker BA, Effron MB, Eur Heart J, 1/1/2010
• Decrease in poor responders on switching from clopidogrel to prasugrel: Results from the SWitching Anti Platelet (SWAP) study.
  Saucedo JF, Angiolillo DJ, DeRaad R, Frelinger AL, Gurbel PA, Costigan TM, Jakubowski JA, Ojeh CK, Effron MB, SWAP Investigators, Circulation, 1/1/2009
• Comparison of prasugel with clopidogrel on platelet function in coronary artery disease patients with type 2 diabetes mellitus - Third Optimizing Anti-Platelet Therapy...
  Angiolillo DJ, Badimon J, Saucedo JF, Frelinger AL, Michelson AD, Jakubowski JA, Zhu B, Ojeh CK, Baker B, Effron MB, Circulation, 1/1/2009
• Reduction in rehospitalizations and associated costs within 30 days after discharge from hospitalization for acute coronary syndromes and planned PCI with prasugrel vs...
  Mahoney EM, Wang K, Bae JP, Zhu B, Marciniak MD, Effron MB, Cohen DJ, Value in Health, 1/1/2009
• Prasugrel and clopidogrel persistence and discontinuation among lower bleeding risk patients undergoing percutaneous coronary intervention for acute coronary syndromes.
  Zhu B, McCollam PL, Bae JP, Ramaswamy K, Johnston JA, Effron MB, Value in Health, 1/1/2009
• Comparison of persistence and adherence between prasugrel and clopidogrel in the treatment of patients with acute coronary syndromes and percutaneous coronary interven...
  Bae JP, Zhu B, McCollam PL, Ramaswamy K, Johnston JA, Cohen DJ, Effron MB, Value in Health, 1/1/2008
• One-year follow-up results of the FINESSE trial of facilitated PCI.
  Ellis SG, Tendera M, De Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O et al, J Am Coll Cardiol, 1/1/2008
• Join now to see all

Lectures

• Optimal Duration of P2Y12 Inhibitor Therapy After Stenting: Is There A Clear Answer? 
  Medical College of Virginia, Richmond, VA, 2014; New Orleans, LA, 2015 - 1/18/2015
• Antithrombotic Therapy in the Treatment of Acute Coronary Syndrome 
  Charleston, WV - 1/17/2014
• Safe PCI for Women: View from the Pharmaceutical Industry 
  White Oak, MD - 1/29/2013
• Drug and device safety: Can we work from common ground? 
  White Oak, MD - 1/4/2012
• Intracranial, GI, & surgical bleeding with more potent agents: A view from industry 
  White Oak, MD - 1/7/2011
• Bleeding, procedural outcomes and other key endpoints/variables - A drug industry view 
  White Oak, MD - 1/23/2010
• Antiplatelet therapy: a paradigm for personalized medicine 
  Krannert Institute of Cardiology, Indiana University School of Medicine - 1/8/2010
• Prasugrel Overview 
  Snowmass, CO - 1/8/2009
• Full disclosure: Trial Registries and Its Effect on Phase IV Studies 
  Philadelphia, PA - 1/19/2005
• Reperfusion Therapy in ST Eleavation Myocardial Infarction (STEMI) - Fibrinolysis, Facilitated PCI, or PCI with Adjunctive Therapy? 
  University of Massachusetts Medical Center, Worcester, MA - 1/5/2005
• The New ACC/AHA STEMI Guidelines - Role of Adjunctive Pharmacotherapeutics for Primary Percutaneous Intervention (PCI) 
  St Vincent Hospital, Worcester, MA - 1/20/2004
• Drotrecogin alfa (activated) in the Treatment of Severe Sepsis 
  Westchester Medical Center, Valhalla, NY - 1/19/2004
• Recent Advances in Therapy Using Glycoprotein IIb/IIIa Receptor Inhibitors 
  Albert Einstein Medical Center, Philadelphia, PA - 1/3/2000
• New Pharmacological Approaches Adjunctive to Interventional Coronary Procedures 
  Jerusalem, Israel - 1/30/1999
• Insights into Abciximab: The Lilly/Centocor Experience 
  Washington, DC - 1/22/1999
• Efficacy and Cost Effectiveness of GP IIb/IIIa Inhibitors 
  Multiple Locations, 1999 - 1/2/1999
• Cost Effectiveness of GP IIb/IIIa Inhibitors 
  Jerusalem, Israel - 1/1/1999
• The CADILLAC Trial; Preliminary Results 
  Jerusalem, Israel - 1/1/1999
• Abciximab Update 
  Latter Day Saints Hospital, Salt Lake City, UT - 1/21/1998
• Use of Platelet Glycoprotein IIb/IIIa Inhibitors in the Treatment of Coronary Artery Disease 
  Tallahassee Memorial Regional Medical Center, Tallahassee, FL, 1997; West Virginia University School - 1/15/1998
• IIb/IIIa receptor inhibitors 
  West Pennsylvania Hospital, Pittsburgh, PA - 1/29/1997
• Antiplatelet therapy in acute coronary syndromes 
  Lankenau Hospital, Wynnewood, PA, 1997; Sinai Hospital of Baltimore, Baltimore, MD, 1997 - 1/13/1997
• Recent trends in inotrope therapy 
  Madras, India - 1/6/1997
• Abciximab, a new potent antiplatelet agent 
  Multiple Locations, 1997 - 1/6/1997
• Use of c7E3 in coronary angioplasty 
  Multiple Locations, 1996 - 1/24/1996
• Join now to see all

Other

• Preventive Cardiology 
  Effron MB
  Northern High School, Baltimore, MD - 1/14/1991
• Clot dissolving drugs 
  Effron MB, "The Heart of the Matter" Radio Program, Series 210A, National Emergency Medicine Association
  1/1/1990